Acellular dermal matrices are tissue allografts derived from human or animal skin which are widely used in soft tissue reconstruction. They serve as scaffolds for cellular repopulation and regeneration and are increasingly used in breast reconstruction, hernia repair, foot and ankle surgery. The global Acellular Dermal Matrices Market is estimated to be valued at US$ 8.8 Bn in 2023 and is expected to exhibit a CAGR of 18% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The demand for acellular dermal matrices is primarily driven by the rising applications in regenerative medicine. With advancement in regenerative therapy techniques, these matrices are gaining more acceptance as skin substitutes and are increasingly being used is reconstructive procedures including breast reconstruction and treatment of acute and chronic wounds. Their ability to facilitate cellular repopulation makes them effective skin substitutes. The growth in number of cosmetic and reconstructive surgical procedures especially in developed markets is expected to boost the demand for acellular dermal matrices over the forecast period.

SWOT Analysis

Strength: Acellular dermal matrices provide an off-the-shelf matrix which is readily available to surgeons. This saves time in procurement and preparation compared to autologous grafts.

Weakness: The acellular dermal matrices are derived from donor tissue and hence carry risks of disease transmission or immune reaction. This raises safety concerns.

Opportunity: With rising cosmetic procedures, there is significant demand for dermal fillers and tissue substitutes. This provides an opportunity to market acellular dermal matrices for aesthetic applications.

Threats: Stiff competition from alternative dermal substitutes like collagen-based matrices threaten the market share of acellular dermal matrices. Cost disadvantages compared to autologous tissues also restrict market growth.

Key Takeaways

The Global Acellular Dermal Matrices Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The market is projected to grow at a CAGR of 18% during this period.

Regional analysis

North America currently dominates the market and is expected to remain the largest market during the forecast period. This can be attributed to factors like high procedural volumes for breast reconstruction and presence of major market players in the US. Asia Pacific is anticipated to grow at the fastest rate owing to rising medical tourism, increasing healthcare awareness and expenditure in the region.

Key players

Key players operating in the acellular dermal matrices market are Regenacy Pharmaceuticals, Inc., Astex Pharmaceuticals, 4SC AG, CellCentric Ltd., Celleron Therapeutics Ltd., Bristol-Myers Squibb Company, Oryzon Genomics S.A., ChromaMedicine, Inc., Epizyme, Inc., and EpiGentek Group Inc. Major players are focusing on new product launches and geographic expansion to consolidate their market position.

https://healthcarelatesteditionnews.blogspot.com/2023/12/demand-for-tissue-regeneration-drives.html